Kennedy, who very well could become Oz's boss if they are both approved by the Senate, appeared to scale back his criticism of the newweight-lossdrug amid his efforts to court support for his ...
The hype and demand of the newweight-lossmedications have shifted not only how health care approaches weight loss, but also (and more importantly) the risk of obesity-related comorbidities ...